Key points from article :
Glucose monitoring leader Dexcom and wearable health tracking company Oura have announced a strategic partnership to integrate continuous glucose monitoring (CGM) with Oura's smart ring technology. Dexcom, which invested $75 million into the Finnish firm, aims to create a combined platform that provides consumers with personalized insights into their metabolic health. By mid-2025, the collaboration plans to introduce app-based features that connect glucose data with sleep, stress, activity, and heart health metrics.
Oura has already sold 2.5 million smart rings and expects to double its annual revenue to $500 million this year. Its latest model, the Oura Ring 4, includes improved sensors for sleep and activity tracking. According to Oura CEO Tom Hale, 97% of Oura users are interested in understanding how diet impacts their health. This partnership aims to provide personalized insights, helping users make informed decisions about what and when to eat by analysing the complex relationships between glucose levels and lifestyle factors.
Dexcom’s glucose monitoring technology, including the non-prescription Stelo biosensor, serves more than 2.5 million users worldwide. The company’s executive vice president, Matt Dolan, emphasized that this collaboration could redefine how metabolic health is managed. The integrated platform promises to attract consumers seeking a comprehensive understanding of how activity, sleep, and nutrition influence glucose levels, paving the way for a more holistic approach to health tracking.
